Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study

J. Bousquet, D.P. Caimmi, A. Bedbrook, M. Bewick, P.W. Hellings, P. Devillier, S. Arnavielhe, C. Bachert, K.C. Bergmann, G.W. Canonica, N.H. Chavannes, A.A. Cruz, R. Dahl, P. Demoly, G. De Vries, E. Mathieu-Dupas, A. Finkwagner, J. Fonseca, N. Guldemond, T. Haahtela & 36 others B. Hellqvist-Dahl, J. Just, T. Keil, L. Klimek, M.L. Kowalski, M. Kuitunen, P. Kuna, V. Kvedariene, D. Laune, A.M. Pereira, P. Carreiro-Martins, E. Melén, M. Morais-Almeida, J. Mullol, A. Muraro, R. Murray, L. Nogueira-Silva, N.G. Papadopoulos, G. Passalacqua, F. Portejoie, D. Price, D. Ryan, B. Samolinski, A. Sheikh, V. Siroux, O. Spranger, A. Todo Bom, P.V. Tomazic, A. Valero, E. Valovirta, A. Valiulis, O. VandenPlas, S. van der Meulen, M. van Eerd, M. Wickman, T. Zuberbier

Research output: Contribution to journalReview article

50 Citations (Scopus)

Abstract

Background: The use of Apps running on smartphones and tablets profoundly affects medicine. The MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) App (Allergy Diary) assesses allergic rhinitis symptoms, disease control and impact on patients’ lives. It is freely available in 20 countries (iOS and Android platforms). Aims: To assess in a pilot study whether (i) Allergy Diary users were able to properly provide baseline characteristics (ii) simple phenotypic characteristics based upon data captured by the Allergy Diary could be identified and (iii) information gathered by this study could suggest novel research questions. Methods: The Allergy Diary users were classified into six groups according to the baseline data that they entered into the App: (i) asymptomatic; (ii) nasal symptoms excluding rhinorrhea; (iii) rhinorrhea; (iv) rhinorrhea plus 1–2 nasal/ocular symptoms; (v) rhinorrhea plus ≥3 nasal/ocular symptoms; and (vi) rhinorrhea plus all nasal/ocular symptoms. Results: By 1 June 2016, 3260 users had registered with the Allergy Diary and 2710 had completed the baseline questionnaire. Troublesome symptoms were found mainly in the users with the most symptoms. Around 50% of users with troublesome rhinitis and/or ocular symptoms suffered work impairment. Sleep was impaired by troublesome symptoms and nasal obstruction. Conclusions: This is the first App (iOS and Android) to have tested for allergic rhinitis and conjunctivitis. A simple questionnaire administered by cell phones enables the identification of phenotypic differences between a priori defined rhinitis groups. The results suggest novel concepts and research questions in allergic rhinitis that may not be identified using classical methods. © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Original languageEnglish
Pages (from-to)857-865
Number of pages9
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume72
Issue number6
DOIs
Publication statusPublished - Jun 2017

Fingerprint

Cell Phones
Hypersensitivity
Nose
Technology
Rhinitis
Allergic Conjunctivitis
Nasal Obstruction
Nuclear Family
Research
Tablets
Sleep
Medicine
cyhalothrin
Allergic Rhinitis

Keywords

  • allergen immunotherapy
  • Allergy Diary
  • EIP on AHA
  • MASK-rhinitis
  • mobile technology

Cite this

Bousquet, J., Caimmi, D. P., Bedbrook, A., Bewick, M., Hellings, P. W., Devillier, P., ... Zuberbier, T. (2017). Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. Allergy: European Journal of Allergy and Clinical Immunology, 72(6), 857-865. https://doi.org/10.1111/all.13125
Bousquet, J. ; Caimmi, D.P. ; Bedbrook, A. ; Bewick, M. ; Hellings, P.W. ; Devillier, P. ; Arnavielhe, S. ; Bachert, C. ; Bergmann, K.C. ; Canonica, G.W. ; Chavannes, N.H. ; Cruz, A.A. ; Dahl, R. ; Demoly, P. ; De Vries, G. ; Mathieu-Dupas, E. ; Finkwagner, A. ; Fonseca, J. ; Guldemond, N. ; Haahtela, T. ; Hellqvist-Dahl, B. ; Just, J. ; Keil, T. ; Klimek, L. ; Kowalski, M.L. ; Kuitunen, M. ; Kuna, P. ; Kvedariene, V. ; Laune, D. ; Pereira, A.M. ; Carreiro-Martins, P. ; Melén, E. ; Morais-Almeida, M. ; Mullol, J. ; Muraro, A. ; Murray, R. ; Nogueira-Silva, L. ; Papadopoulos, N.G. ; Passalacqua, G. ; Portejoie, F. ; Price, D. ; Ryan, D. ; Samolinski, B. ; Sheikh, A. ; Siroux, V. ; Spranger, O. ; Todo Bom, A. ; Tomazic, P.V. ; Valero, A. ; Valovirta, E. ; Valiulis, A. ; VandenPlas, O. ; van der Meulen, S. ; van Eerd, M. ; Wickman, M. ; Zuberbier, T. / Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. In: Allergy: European Journal of Allergy and Clinical Immunology. 2017 ; Vol. 72, No. 6. pp. 857-865.
@article{4bd9e630423b4dbc8866eefc9d0e4d0a,
title = "Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study",
abstract = "Background: The use of Apps running on smartphones and tablets profoundly affects medicine. The MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) App (Allergy Diary) assesses allergic rhinitis symptoms, disease control and impact on patients’ lives. It is freely available in 20 countries (iOS and Android platforms). Aims: To assess in a pilot study whether (i) Allergy Diary users were able to properly provide baseline characteristics (ii) simple phenotypic characteristics based upon data captured by the Allergy Diary could be identified and (iii) information gathered by this study could suggest novel research questions. Methods: The Allergy Diary users were classified into six groups according to the baseline data that they entered into the App: (i) asymptomatic; (ii) nasal symptoms excluding rhinorrhea; (iii) rhinorrhea; (iv) rhinorrhea plus 1–2 nasal/ocular symptoms; (v) rhinorrhea plus ≥3 nasal/ocular symptoms; and (vi) rhinorrhea plus all nasal/ocular symptoms. Results: By 1 June 2016, 3260 users had registered with the Allergy Diary and 2710 had completed the baseline questionnaire. Troublesome symptoms were found mainly in the users with the most symptoms. Around 50{\%} of users with troublesome rhinitis and/or ocular symptoms suffered work impairment. Sleep was impaired by troublesome symptoms and nasal obstruction. Conclusions: This is the first App (iOS and Android) to have tested for allergic rhinitis and conjunctivitis. A simple questionnaire administered by cell phones enables the identification of phenotypic differences between a priori defined rhinitis groups. The results suggest novel concepts and research questions in allergic rhinitis that may not be identified using classical methods. {\circledC} 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd",
keywords = "allergen immunotherapy, Allergy Diary, EIP on AHA, MASK-rhinitis, mobile technology",
author = "J. Bousquet and D.P. Caimmi and A. Bedbrook and M. Bewick and P.W. Hellings and P. Devillier and S. Arnavielhe and C. Bachert and K.C. Bergmann and G.W. Canonica and N.H. Chavannes and A.A. Cruz and R. Dahl and P. Demoly and {De Vries}, G. and E. Mathieu-Dupas and A. Finkwagner and J. Fonseca and N. Guldemond and T. Haahtela and B. Hellqvist-Dahl and J. Just and T. Keil and L. Klimek and M.L. Kowalski and M. Kuitunen and P. Kuna and V. Kvedariene and D. Laune and A.M. Pereira and P. Carreiro-Martins and E. Mel{\'e}n and M. Morais-Almeida and J. Mullol and A. Muraro and R. Murray and L. Nogueira-Silva and N.G. Papadopoulos and G. Passalacqua and F. Portejoie and D. Price and D. Ryan and B. Samolinski and A. Sheikh and V. Siroux and O. Spranger and {Todo Bom}, A. and P.V. Tomazic and A. Valero and E. Valovirta and A. Valiulis and O. VandenPlas and {van der Meulen}, S. and {van Eerd}, M. and M. Wickman and T. Zuberbier",
year = "2017",
month = "6",
doi = "10.1111/all.13125",
language = "English",
volume = "72",
pages = "857--865",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Blackwell Publishing Ltd",
number = "6",

}

Bousquet, J, Caimmi, DP, Bedbrook, A, Bewick, M, Hellings, PW, Devillier, P, Arnavielhe, S, Bachert, C, Bergmann, KC, Canonica, GW, Chavannes, NH, Cruz, AA, Dahl, R, Demoly, P, De Vries, G, Mathieu-Dupas, E, Finkwagner, A, Fonseca, J, Guldemond, N, Haahtela, T, Hellqvist-Dahl, B, Just, J, Keil, T, Klimek, L, Kowalski, ML, Kuitunen, M, Kuna, P, Kvedariene, V, Laune, D, Pereira, AM, Carreiro-Martins, P, Melén, E, Morais-Almeida, M, Mullol, J, Muraro, A, Murray, R, Nogueira-Silva, L, Papadopoulos, NG, Passalacqua, G, Portejoie, F, Price, D, Ryan, D, Samolinski, B, Sheikh, A, Siroux, V, Spranger, O, Todo Bom, A, Tomazic, PV, Valero, A, Valovirta, E, Valiulis, A, VandenPlas, O, van der Meulen, S, van Eerd, M, Wickman, M & Zuberbier, T 2017, 'Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study', Allergy: European Journal of Allergy and Clinical Immunology, vol. 72, no. 6, pp. 857-865. https://doi.org/10.1111/all.13125

Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. / Bousquet, J.; Caimmi, D.P.; Bedbrook, A.; Bewick, M.; Hellings, P.W.; Devillier, P.; Arnavielhe, S.; Bachert, C.; Bergmann, K.C.; Canonica, G.W.; Chavannes, N.H.; Cruz, A.A.; Dahl, R.; Demoly, P.; De Vries, G.; Mathieu-Dupas, E.; Finkwagner, A.; Fonseca, J.; Guldemond, N.; Haahtela, T.; Hellqvist-Dahl, B.; Just, J.; Keil, T.; Klimek, L.; Kowalski, M.L.; Kuitunen, M.; Kuna, P.; Kvedariene, V.; Laune, D.; Pereira, A.M.; Carreiro-Martins, P.; Melén, E.; Morais-Almeida, M.; Mullol, J.; Muraro, A.; Murray, R.; Nogueira-Silva, L.; Papadopoulos, N.G.; Passalacqua, G.; Portejoie, F.; Price, D.; Ryan, D.; Samolinski, B.; Sheikh, A.; Siroux, V.; Spranger, O.; Todo Bom, A.; Tomazic, P.V.; Valero, A.; Valovirta, E.; Valiulis, A.; VandenPlas, O.; van der Meulen, S.; van Eerd, M.; Wickman, M.; Zuberbier, T.

In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 72, No. 6, 06.2017, p. 857-865.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study

AU - Bousquet, J.

AU - Caimmi, D.P.

AU - Bedbrook, A.

AU - Bewick, M.

AU - Hellings, P.W.

AU - Devillier, P.

AU - Arnavielhe, S.

AU - Bachert, C.

AU - Bergmann, K.C.

AU - Canonica, G.W.

AU - Chavannes, N.H.

AU - Cruz, A.A.

AU - Dahl, R.

AU - Demoly, P.

AU - De Vries, G.

AU - Mathieu-Dupas, E.

AU - Finkwagner, A.

AU - Fonseca, J.

AU - Guldemond, N.

AU - Haahtela, T.

AU - Hellqvist-Dahl, B.

AU - Just, J.

AU - Keil, T.

AU - Klimek, L.

AU - Kowalski, M.L.

AU - Kuitunen, M.

AU - Kuna, P.

AU - Kvedariene, V.

AU - Laune, D.

AU - Pereira, A.M.

AU - Carreiro-Martins, P.

AU - Melén, E.

AU - Morais-Almeida, M.

AU - Mullol, J.

AU - Muraro, A.

AU - Murray, R.

AU - Nogueira-Silva, L.

AU - Papadopoulos, N.G.

AU - Passalacqua, G.

AU - Portejoie, F.

AU - Price, D.

AU - Ryan, D.

AU - Samolinski, B.

AU - Sheikh, A.

AU - Siroux, V.

AU - Spranger, O.

AU - Todo Bom, A.

AU - Tomazic, P.V.

AU - Valero, A.

AU - Valovirta, E.

AU - Valiulis, A.

AU - VandenPlas, O.

AU - van der Meulen, S.

AU - van Eerd, M.

AU - Wickman, M.

AU - Zuberbier, T.

PY - 2017/6

Y1 - 2017/6

N2 - Background: The use of Apps running on smartphones and tablets profoundly affects medicine. The MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) App (Allergy Diary) assesses allergic rhinitis symptoms, disease control and impact on patients’ lives. It is freely available in 20 countries (iOS and Android platforms). Aims: To assess in a pilot study whether (i) Allergy Diary users were able to properly provide baseline characteristics (ii) simple phenotypic characteristics based upon data captured by the Allergy Diary could be identified and (iii) information gathered by this study could suggest novel research questions. Methods: The Allergy Diary users were classified into six groups according to the baseline data that they entered into the App: (i) asymptomatic; (ii) nasal symptoms excluding rhinorrhea; (iii) rhinorrhea; (iv) rhinorrhea plus 1–2 nasal/ocular symptoms; (v) rhinorrhea plus ≥3 nasal/ocular symptoms; and (vi) rhinorrhea plus all nasal/ocular symptoms. Results: By 1 June 2016, 3260 users had registered with the Allergy Diary and 2710 had completed the baseline questionnaire. Troublesome symptoms were found mainly in the users with the most symptoms. Around 50% of users with troublesome rhinitis and/or ocular symptoms suffered work impairment. Sleep was impaired by troublesome symptoms and nasal obstruction. Conclusions: This is the first App (iOS and Android) to have tested for allergic rhinitis and conjunctivitis. A simple questionnaire administered by cell phones enables the identification of phenotypic differences between a priori defined rhinitis groups. The results suggest novel concepts and research questions in allergic rhinitis that may not be identified using classical methods. © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd

AB - Background: The use of Apps running on smartphones and tablets profoundly affects medicine. The MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) App (Allergy Diary) assesses allergic rhinitis symptoms, disease control and impact on patients’ lives. It is freely available in 20 countries (iOS and Android platforms). Aims: To assess in a pilot study whether (i) Allergy Diary users were able to properly provide baseline characteristics (ii) simple phenotypic characteristics based upon data captured by the Allergy Diary could be identified and (iii) information gathered by this study could suggest novel research questions. Methods: The Allergy Diary users were classified into six groups according to the baseline data that they entered into the App: (i) asymptomatic; (ii) nasal symptoms excluding rhinorrhea; (iii) rhinorrhea; (iv) rhinorrhea plus 1–2 nasal/ocular symptoms; (v) rhinorrhea plus ≥3 nasal/ocular symptoms; and (vi) rhinorrhea plus all nasal/ocular symptoms. Results: By 1 June 2016, 3260 users had registered with the Allergy Diary and 2710 had completed the baseline questionnaire. Troublesome symptoms were found mainly in the users with the most symptoms. Around 50% of users with troublesome rhinitis and/or ocular symptoms suffered work impairment. Sleep was impaired by troublesome symptoms and nasal obstruction. Conclusions: This is the first App (iOS and Android) to have tested for allergic rhinitis and conjunctivitis. A simple questionnaire administered by cell phones enables the identification of phenotypic differences between a priori defined rhinitis groups. The results suggest novel concepts and research questions in allergic rhinitis that may not be identified using classical methods. © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd

KW - allergen immunotherapy

KW - Allergy Diary

KW - EIP on AHA

KW - MASK-rhinitis

KW - mobile technology

U2 - 10.1111/all.13125

DO - 10.1111/all.13125

M3 - Review article

VL - 72

SP - 857

EP - 865

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0105-4538

IS - 6

ER -